(Total Views: 195)
Posted On: 03/02/2018 2:05:40 PM
Post# of 15624
A company that truly wanted to get involved would be far smarter to partner with OWCP and take a solid ownership position with a substantial cash infusion into the company. With 20% or more they should get a seat on the board and frankly would make more than if they acquired the company as they worked to build the share price. They could see their shares rise thousands of percentage points in building the company which could be worth more than if they acquired it.
At some point in the future they could easily acquire it as an alliance with major institutions who would own major portions of the company by then could easily force an agreement to buy it out. They could then spin it off maintaining a majority interest, just as Roche did with Genentech a few times, and could do again.
Such a partnership would immediately have the share price well over a dollar and the company would have funding sufficient to operate for years and expand both staff and their trial efforts. I believe this is the sort of thing we may see, not a buyout.
Gary
At some point in the future they could easily acquire it as an alliance with major institutions who would own major portions of the company by then could easily force an agreement to buy it out. They could then spin it off maintaining a majority interest, just as Roche did with Genentech a few times, and could do again.
Such a partnership would immediately have the share price well over a dollar and the company would have funding sufficient to operate for years and expand both staff and their trial efforts. I believe this is the sort of thing we may see, not a buyout.
Gary
(1)
(0)Scroll down for more posts ▼
